Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yixuan Gong

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Current Topics in Microbiology and Immunology|August 26, 2011
EGFR mutant lung cancerYixuan Gong, William Pao
Molecular Pharmacology|December 31, 2005
3,3'-diindolylmethane is a novel topoisomerase IIalpha catalytic inhibitor that induces S-phase retardation and mitotic delay in human hepatoma HepG2 cellsYixuan Gong, Gary L Firestone, Leonard F Bjeldanes
Cancers|July 1, 2014
Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progressionYixuan Gong, Uma D Chippada-Venkata, William K Oh
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|March 18, 2019
N-doped carbon dots under Xenon lamp irradiation: Fluorescence red-shift and its potential mechanismHongwei Hu, Xinmeng Tian, Yixuan Gong, et al.
Biochemical and Biophysical Research Communications|January 26, 2020
Mutation of leucine 20 causes a change of local conformation indirectly impairing the DNA binding of SP_0782 from Streptococcus pneumoniaeYixuan Gong, Shuangli Li, Ying Li, et al.
Cancer Research|May 3, 2006
3,3'-Diindolylmethane is a novel mitochondrial H(+)-ATP synthase inhibitor that can induce p21(Cip1/Waf1) expression by induction of oxidative stress in human breast cancer cellsYixuan Gong, Heesook Sohn, Ling Xue, et al.
Frontiers in Surgery|October 20, 2025
Efficacy of postoperative adjuvant hepatic artery infusion chemotherapy for hepatocellular carcinoma in microvascular invasion: a propensity-matched scoreXu Feng, Xinhua Wu, Kai Chen, et al.
Plos One|October 22, 2013
TIMP-1 promotes accumulation of cancer associated fibroblasts and cancer progressionYixuan Gong, Evita Scott, Rong Lu, et al.
Plos Medicine|October 12, 2007
Induction of BIM is essential for apoptosis triggered by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomasYixuan Gong, Romel Somwar, Katerina Politi, et al.
Oncotarget|September 15, 2016
Constructing Bayesian networks by integrating gene expression and copy number data identifies NLGN4Y as a novel regulator of prostate cancer progressionYixuan Gong, Li Wang, Uma Chippada-Venkata, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Current Topics in Microbiology and Immunology|August 26, 2011
EGFR mutant lung cancerYixuan Gong, William Pao
Molecular Pharmacology|December 31, 2005
3,3'-diindolylmethane is a novel topoisomerase IIalpha catalytic inhibitor that induces S-phase retardation and mitotic delay in human hepatoma HepG2 cellsYixuan Gong, Gary L Firestone, Leonard F Bjeldanes
Cancers|July 1, 2014
Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progressionYixuan Gong, Uma D Chippada-Venkata, William K Oh
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|March 18, 2019
N-doped carbon dots under Xenon lamp irradiation: Fluorescence red-shift and its potential mechanismHongwei Hu, Xinmeng Tian, Yixuan Gong, et al.
Biochemical and Biophysical Research Communications|January 26, 2020
Mutation of leucine 20 causes a change of local conformation indirectly impairing the DNA binding of SP_0782 from Streptococcus pneumoniaeYixuan Gong, Shuangli Li, Ying Li, et al.
Cancer Research|May 3, 2006
3,3'-Diindolylmethane is a novel mitochondrial H(+)-ATP synthase inhibitor that can induce p21(Cip1/Waf1) expression by induction of oxidative stress in human breast cancer cellsYixuan Gong, Heesook Sohn, Ling Xue, et al.
Frontiers in Surgery|October 20, 2025
Efficacy of postoperative adjuvant hepatic artery infusion chemotherapy for hepatocellular carcinoma in microvascular invasion: a propensity-matched scoreXu Feng, Xinhua Wu, Kai Chen, et al.
Plos One|October 22, 2013
TIMP-1 promotes accumulation of cancer associated fibroblasts and cancer progressionYixuan Gong, Evita Scott, Rong Lu, et al.
Plos Medicine|October 12, 2007
Induction of BIM is essential for apoptosis triggered by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomasYixuan Gong, Romel Somwar, Katerina Politi, et al.
Oncotarget|September 15, 2016
Constructing Bayesian networks by integrating gene expression and copy number data identifies NLGN4Y as a novel regulator of prostate cancer progressionYixuan Gong, Li Wang, Uma Chippada-Venkata, et al.
Pageof 4